5 August 2011 - Consolidated Financial Results for the Half Year Ended 30 June 2011
. Sales increased 03.00% to US$7,008,496 (2010 US$6,990,345)
. Net profit increased 25.30% to US$2,743,096 (2010) US$2,189.007)
. Net profit margin increased to 39.10% from (2010 31.30%)
. Total assets increased 36.30% to US$13,694,726 (2010 US$10,049,085)
. Net asset value per share increased 34.70% to $US$8.23 (2010 US$6.11)
. Cash and deposits increased 94.00% to US$4,842,150 (2009 US$2,496,339) The Company has not debt
. Net profit per share was US$1.92 (2010 US$1.53) an increase of 25.50%
. Interim dividend US$0.50 to be paid to shareholder in September 2011 (2010 US$0.50)
The shares are traded over the counter in Hong Kong.
original shareholders acquired their holding in Pharmalink having been shareholders in Special Assets Limited (HK.B12179)
.
Company´s websites www.lyprinol.com and www.OmegaXL.com - Email skwok@sal.com.hk
.
No comments:
Post a Comment